Becker's Healthcare May 17, 2024
Paige Twenter

Amgen’s Imdelltra is the first and only T-cell engager therapy approved for extensive-stage small cell lung cancer, an aggressive, stubborn cancer that spreads through the body.

On May 16, the FDA granted Imdelltra an accelerated approval. In a trial with 99 study participants with symptomatic brain metastases,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies
Opinion: STAT+: How will the Center for Biologics Evaluation and Research change under RFK Jr.?
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder
FDA nominee pitches AI application review
Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA He Railed Against
Project Optimus: The evolution of dose optimisation in oncology

Share This Article